CLOPIDOGREL BISULFATE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 18 adverse event reports in the FDA FAERS database where CLOPIDOGREL BISULFATE was used for Psoriasis.
Most Reported Side Effects for CLOPIDOGREL BISULFATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Gastrointestinal haemorrhage | 5,513 | 12.0% | 904 | 3,687 |
| Anaemia | 3,043 | 6.6% | 205 | 2,603 |
| Dyspnoea | 1,963 | 4.3% | 194 | 1,252 |
| Drug interaction | 1,846 | 4.0% | 198 | 1,100 |
| Haemorrhage | 1,762 | 3.8% | 224 | 765 |
| Drug ineffective | 1,644 | 3.6% | 172 | 789 |
| Cerebral haemorrhage | 1,603 | 3.5% | 625 | 722 |
| Dizziness | 1,586 | 3.5% | 42 | 873 |
| Epistaxis | 1,560 | 3.4% | 176 | 890 |
| Melaena | 1,547 | 3.4% | 104 | 1,273 |
| Fatigue | 1,530 | 3.3% | 53 | 688 |
| Haematochezia | 1,390 | 3.0% | 62 | 1,193 |
| Myocardial infarction | 1,337 | 2.9% | 163 | 681 |
| Rectal haemorrhage | 1,333 | 2.9% | 131 | 1,002 |
| Asthenia | 1,310 | 2.9% | 153 | 892 |
Other Indications for CLOPIDOGREL BISULFATE
Product used for unknown indication (14,627)
Antiplatelet therapy (3,520)
Stent placement (1,909)
Coronary artery disease (1,584)
Thrombosis prophylaxis (1,529)
Cerebrovascular accident (1,415)
Myocardial infarction (1,365)
Anticoagulant therapy (1,340)
Prophylaxis (1,296)
Acute coronary syndrome (1,292)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)